Pinnacle Associates Ltd. lifted its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 2.1% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,552 shares of the medical equipment provider’s stock after purchasing an additional 53 shares during the quarter. Pinnacle Associates Ltd.’s holdings in Intuitive Surgical were worth $1,254,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other large investors also recently modified their holdings of the company. Vanguard Group Inc. grew its holdings in shares of Intuitive Surgical by 1.6% in the first quarter. Vanguard Group Inc. now owns 30,868,620 shares of the medical equipment provider’s stock worth $12,319,358,000 after acquiring an additional 493,126 shares during the period. Capital World Investors grew its holdings in shares of Intuitive Surgical by 1.0% in the first quarter. Capital World Investors now owns 7,284,269 shares of the medical equipment provider’s stock worth $2,907,079,000 after acquiring an additional 73,634 shares during the period. Jennison Associates LLC grew its holdings in shares of Intuitive Surgical by 4.6% in the first quarter. Jennison Associates LLC now owns 4,488,343 shares of the medical equipment provider’s stock worth $1,791,253,000 after acquiring an additional 198,483 shares during the period. American Century Companies Inc. grew its holdings in shares of Intuitive Surgical by 3.0% in the second quarter. American Century Companies Inc. now owns 2,398,193 shares of the medical equipment provider’s stock worth $1,066,837,000 after acquiring an additional 70,556 shares during the period. Finally, Clearbridge Investments LLC grew its holdings in shares of Intuitive Surgical by 1.6% in the second quarter. Clearbridge Investments LLC now owns 1,981,297 shares of the medical equipment provider’s stock worth $881,380,000 after acquiring an additional 30,449 shares during the period. Institutional investors own 83.64% of the company’s stock.
Intuitive Surgical Trading Up 0.5 %
NASDAQ:ISRG opened at $506.34 on Friday. The company has a market capitalization of $180.35 billion, a P/E ratio of 81.41, a P/E/G ratio of 5.05 and a beta of 1.39. Intuitive Surgical, Inc. has a 12 month low of $269.49 and a 12 month high of $523.34. The business’s 50-day moving average is $490.41 and its 200 day moving average is $446.60.
Insider Buying and Selling at Intuitive Surgical
Wall Street Analyst Weigh In
Several analysts have issued reports on ISRG shares. Wells Fargo & Company boosted their price target on Intuitive Surgical from $466.00 to $549.00 and gave the company an “overweight” rating in a report on Friday, October 18th. JPMorgan Chase & Co. boosted their price target on Intuitive Surgical from $495.00 to $575.00 and gave the company an “overweight” rating in a report on Friday, October 11th. Citigroup boosted their price target on Intuitive Surgical from $512.00 to $560.00 and gave the company a “buy” rating in a report on Thursday, August 22nd. Stifel Nicolaus boosted their price target on Intuitive Surgical from $475.00 to $525.00 and gave the company a “buy” rating in a report on Friday, October 18th. Finally, Barclays boosted their price target on Intuitive Surgical from $430.00 to $490.00 and gave the company an “overweight” rating in a report on Thursday, July 18th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and fourteen have issued a buy rating to the stock. Based on data from MarketBeat.com, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and a consensus price target of $513.74.
View Our Latest Stock Analysis on ISRG
Intuitive Surgical Company Profile
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Featured Articles
- Five stocks we like better than Intuitive Surgical
- Why Invest in High-Yield Dividend Stocks?
- Energy Vault Soars 100%: CEO Shares Why in MarketBeat Exclusive
- What is the NASDAQ Stock Exchange?
- Meta’s Q3 Earnings Beat—Is This Dip a Golden Entry Opportunity?
- Manufacturing Stocks Investing
- Top Nuclear Stocks Thriving on Soaring Energy Demand
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.